News
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...
The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.
Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...
Momentum is building to scale back the current recommendation that all children over 6 months old get immunized against the ...
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
Columbia University and NewYork-Presbyterian Hospital agreed to pay $750 million to settle hundreds of sexual abuse claims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results